Scynexis, a drug discovery focused firm based in RTP, will provide its drug discovery software platform called HEOS to the TB Alliance.

Financial terms were not disclosed.

TB Alliance plans to use the software for research into fighting tuberculosis.

HEOS is delivered in the form of software-as-a-service and is accessible in a cloud-based format, enabling teams of researchers to collaborate online.

Read more details here.

Get the latest news alerts: Follow LTW at Twitter.